Description
Alaktin (Cabergoline) Tablets 0.5 mg. №2 Vial
Composition
Active ingredient: Cabergoline 0.5 mg per tablet.
Mechanism of Action
Cabergoline, the active ingredient in Alaktin tablets, is a dopamine receptor agonist that works by reducing the secretion of prolactin from the pituitary gland.
Pharmacological Properties
Cabergoline acts on dopamine receptors, specifically D2 receptors, inhibiting the release of prolactin. It has a longer duration of action compared to other dopamine agonists.
Indications for Use
Alaktin tablets are indicated for the treatment of hyperprolactinemia, disorders associated with high levels of prolactin hormone.
Contraindications
Do not use Alaktin tablets if you are allergic to cabergoline or any other ingredients in the product. Consult a healthcare provider before use.
Side Effects
Common side effects may include nausea, dizziness, constipation, and fatigue. Serious side effects such as hallucinations or chest pain should be reported to a healthcare provider immediately.
Usage Instructions
Take Alaktin tablets orally with or without food as directed by your healthcare provider. The usual recommended dose is 0.25 mg twice a week. Dosage may vary based on individual response and medical condition. Do not exceed the recommended dose.
Benefits Compared to Analogues
Compared to other medications for hyperprolactinemia, cabergoline has shown superior efficacy and tolerability with fewer side effects. It also requires less frequent dosing, enhancing patient compliance.
Suitable Patient Groups
Alaktin tablets are suitable for adults of all ages, including the elderly. Use in children should be under the supervision of a healthcare provider.
Storage and Shelf Life
Store Alaktin tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product if expired.
Packaging Description
Alaktin tablets are available in a vial containing 2 tablets of 0.5 mg each. The packaging is designed to protect the tablets from moisture and ensure their integrity.
Clinical Evidence and Proven Effectiveness
Clinical studies have shown that cabergoline is effective in normalizing prolactin levels and improving symptoms associated with hyperprolactinemia. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated the efficacy and safety of cabergoline in long-term use for patients with hyperprolactinemia.
Additional Information
It is important to follow the dosage instructions provided by your healthcare provider to achieve the best results with Alaktin tablets. Regular monitoring of prolactin levels may be necessary during treatment to assess the response to therapy. Discuss with your healthcare provider about any other medications or medical conditions you have before starting Alaktin tablets to avoid potential drug interactions or complications.
